Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon Aug 09, 2021 12:27pm
143 Views
Post# 33672219

RE:RE:RE:4 new directors at Dialco, all directly reporting to Seto.

RE:RE:RE:4 new directors at Dialco, all directly reporting to Seto.
Revten wrote:

We will see who has the last Ha Ha Ha Ha Ha Ha when the Share Price hits not .80 Cents but $8.00! 

Everything is Progressing EXACTLY as Planned!
 

Dialco's Success will SHOCK everyone! They have a Superior Product launching into a $10 Billion Dollar Market that is Growing Exponentially due to aging population! No Brainer!

The Tigris will be an OVERWHELMING SUCCESS! ...

Patience will PAY OFF in the form of a King's Ransom!

have been adding Substantially over the last 2 weeks!

NOT on Margin in anyway shape or form!! 


REV-UP and Still Buying and Holding Strong!!



I like your enthusiam Revten !

Like yourself, I have been adding alot in this price range.

Companies with far less to offer the medical community are trading for far more than Spectral.

Where else can you get a Company that has a Phase 3b "confirmatory" Trial for the first new treatement for Sepsis in 2 - 3 decades?  (something that kills > 10M people per year = 2.5 times all Covid deaths so far).  Apparently early results are very good, albeit slow. That's presumaby another reason why we were able to land a KOL to get things unstuck, and moving again.

Or a Company that has game-changing CRRT technology, that WILL better address the home Dialysis market within 12 months or so?  (needed now more than ever for reasons of cost, better outcomes, increasing AKI, and safety reasons)

I watch insider positioning at these give-away LOW prices to get my best clues (i.e. whether to BUY or SELL).  Thier actions of late, has also led me to a decision to accumulate more at rock bottom prices.

glta

MM



<< Previous
Bullboard Posts
Next >>